Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression.
Jordan
M L
ML
Department of Urology and the Pittsburgh Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Chakrabarti
P
P
Luke
P P
PP
Shapiro
R
R
Vivas
C A
CA
Scantlebury
V P
VP
Hakala
T R
TR
Fedorek
S
S
Corry
R J
RJ
D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology* / Q000401:mortality; D012306:Risk; D013256:Steroids / Q000008:administration & dosage*; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D013256:Steroids; D009173:Mycophenolic Acid; D016559:Tacrolimus